Of particular relevance to VSV-based approaches, this group demonstrated that replacing the native VSV-G with glycoproteins from heterologous viruses reduced neurotoxicity without compromising the ability of VSV to kill tumor cells [47]. Here, ART4 is linked to neoplasm.